High-Dose Rifampicin Mediated Systemic Alterations of Cytokines, Chemokines, Growth Factors, Microbial Translocation Markers, and Acute-Phase Proteins in Pulmonary Tuberculosis

High-dose rifampicin (HDR) is now undergoing clinical trials to improve the efficacy of anti-tuberculosis treatment (ATT). However, the influence of HDR in the modulation of different cytokines, chemokines/growth factors, microbial translocation markers (MTMs), and acute-phase proteins (APPs) in pul...

Descripción completa

Detalles Bibliográficos
Autores principales: Kathamuthu, Gokul Raj, Bhavani, Perumal Kannabiran, Singh, Manjula, Saini, Jitendra Kumar, Aggarwal, Ashutosh, Ansari, Mohammed Soheb S., Garg, Rajiv, Babu, Subash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335011/
https://www.ncbi.nlm.nih.gov/pubmed/35910352
http://dx.doi.org/10.3389/fphar.2022.896551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335011/
https://www.ncbi.nlm.nih.gov/pubmed/35910352
http://dx.doi.org/10.3389/fphar.2022.896551

Ejemplares similares